No abstract available
MeSH terms
-
Abdominal Cavity
-
Acute Kidney Injury / chemically induced
-
Axitinib
-
Carcinoma, Renal Cell* / pathology
-
Carcinoma, Renal Cell* / therapy
-
Combined Modality Therapy
-
Everolimus
-
Humans
-
Imidazoles / administration & dosage
-
Imidazoles / adverse effects
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Indazoles / administration & dosage
-
Indazoles / adverse effects
-
Interferon-alpha / administration & dosage
-
Interferon-alpha / adverse effects
-
Kidney Neoplasms* / pathology
-
Kidney Neoplasms* / therapy
-
Lymph Node Excision* / adverse effects
-
Lymph Node Excision* / methods
-
Lymph Nodes / pathology*
-
Lymphatic Metastasis
-
Male
-
Middle Aged
-
Neoplasm Recurrence, Local
-
Neoplasm Staging
-
Nephrectomy / methods*
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / adverse effects
-
Remission Induction
-
Sirolimus / administration & dosage
-
Sirolimus / analogs & derivatives*
-
Tomography, X-Ray Computed
-
Withholding Treatment
Substances
-
Imidazoles
-
Immunosuppressive Agents
-
Indazoles
-
Interferon-alpha
-
Protein Kinase Inhibitors
-
Everolimus
-
Axitinib
-
Sirolimus